Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients - 2Nodding off is dangerous. Some animals have evolved extreme ways to sleep in precarious environments
- 3What you need to know about desalination, a growing source of drinking water
- 4First part of major new German-Danish tunnel cleared for lowering
- 5This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- Geminid meteor shower, one of the year's most reliable, peaks this weekend
- Kendall Jenner addresses long-standing rumor about her sexuality
- Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- Vote In favor of Your Favored Kind Of Bites
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- Kate Middleton and Prince William unveil annual family Christmas card photo with George, Charlotte and Louis
- Green Inflections: A Manual for Inside Plants
- EPA watchdog finds nation’s most contaminated sites are vulnerable to flooding, wildfires
- 4 Must-Visit bar-b-que Eateries This Year
